These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4811226)

  • 21. Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release.
    Cassady JM; Li GS; Spitzner EB; Floss HG; Clemens JA
    J Med Chem; 1974 Mar; 17(3):300-7. PubMed ID: 4811225
    [No Abstract]   [Full Text] [Related]  

  • 22. Heterogeneous turnover of adenohypophysial prolactin.
    Swearingen KC
    Endocrinology; 1971 Dec; 89(6):1380-8. PubMed ID: 5120638
    [No Abstract]   [Full Text] [Related]  

  • 23. Adenosine 3',5'-monophosphate derivatives increase prolactin synthesis and prolactin messenger ribonucleic acid levels in ergocryptine-treated pituitary cells.
    Maurer RA
    Endocrinology; 1982 Jun; 110(6):1957-63. PubMed ID: 6280981
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition by 2-Br alpha-ergocryptine-mesilate (CB-154) of suckling-induced pituitary prolactin depletion in lactating rats.
    Flückiger E; Kovacs E
    Experientia; 1974 Oct; 30(10):1173. PubMed ID: 4435126
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence that autoregulation of prolactin production does not occur at the pituitary level.
    Vician L; Lieberman ME; Gorski J
    Endocrinology; 1982 Mar; 110(3):722-6. PubMed ID: 6895725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity.
    McQuaid LA; Latz JE; Clemens JA; Fuller RW; Wong DT; Mason NR
    J Med Chem; 1989 Oct; 32(10):2388-96. PubMed ID: 2571732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
    Lloyd HM; Meares JD; Jacobi J
    Nature; 1975 Jun; 255(5508):497-8. PubMed ID: 1138203
    [No Abstract]   [Full Text] [Related]  

  • 28. Short-term effect of estrogen on release of prolactin by pituitary cells in culture.
    Zyzek E; Dufy-Barbe L; Dufy B; Vincent JD
    Biochem Biophys Res Commun; 1981 Oct; 102(4):1151-7. PubMed ID: 7317045
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of ergotamine tartrate on prolactin and growth hormone secretion by rat adenohypophysis in vitro.
    Nicoll CS; Yaron Z; Nutt N; Daniels E
    Biol Reprod; 1971 Aug; 5(1):59-66. PubMed ID: 4942737
    [No Abstract]   [Full Text] [Related]  

  • 30. 2-hydroxyoestradiol inhibits prolactin release from the superfused rat pituitary gland.
    Linton EA; White N; Lira de Tineo O; Jeffcoate SL
    J Endocrinol; 1981 Sep; 90(3):315-22. PubMed ID: 7276793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
    Oomizu S; Boyadjieva N; Sarkar DK
    Alcohol Clin Exp Res; 2003 Jun; 27(6):975-80. PubMed ID: 12824819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists.
    Bach NJ; Kornfeld EC; Jones ND; Chaney MO; Dorman DE; Paschal JW; Clemens JA; Smalstig EB
    J Med Chem; 1980 May; 23(5):481-91. PubMed ID: 7189782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive ergolinepropionamides.
    Bernardi L; Bosisio G; Mantegani S; Sapini O; Temperilli A; Salvati P; di Salle E; Arcari G; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1094-8. PubMed ID: 6685485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of biological effects of N-alkylated congeners of beta-phenethylamine derived from 2-aminotetralin, 2-aminoindan, and 6-aminobenzocycloheptene.
    Cannon JG; Perez JA; Pease JP; Long JP; Flynn JR; Rusterholz DB; Dryer SE
    J Med Chem; 1980 Jul; 23(7):745-9. PubMed ID: 7190613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of D-6-methyl-8-ergoline-I-ylacetamide (Deprenon) on the FSH content of the rat pituitary during the oestrus cycle and pregnancy.
    Chlebounová J; Rezábek K; Seda M; Semonský M
    Physiol Bohemoslov; 1974; 23(2):113-8. PubMed ID: 4280585
    [No Abstract]   [Full Text] [Related]  

  • 36. Ergot alkaloids. Synthesis of 6-alkyl-8-ergolenes and 6-methyl-8-aminoergolines as potential prolactin inhibitors.
    Crider AM; Robinson JM; Floss HG; Cassady JM; Clemens JA
    J Med Chem; 1977 Nov; 20(11):1473-7. PubMed ID: 915908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ovariectomy and of oestrogen administration on the decrease in pituitary prolactin content which occurs on the afternoon of pro-oestrus in the rat.
    Yokoyama A; Tomagane H; Ota K
    Experientia; 1971 Oct; 27(10):1221-2. PubMed ID: 5166734
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
    Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
    Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
    [No Abstract]   [Full Text] [Related]  

  • 40. Oestrogenic effects of catechol oestrogens on secretion of prolactin by the pituitary gland and synthesis of DNA by the mammary gland in ovariectomized rats.
    Yanai R; Nagasawa H
    J Endocrinol; 1979 Jul; 82(1):131-3. PubMed ID: 479728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.